Skip to main content
OpenTrials
Recruiting

NCT Number: NCT01670383

Repository for Sepsis and Postresuscitation Samples

The objective of this study is to find a new therapeutic strategy by investigating the serial serum samples of patients with sepsis or postresuscitation state.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Cardiac Arrest Cardiovascular Diseases Heart Arrest Heart Diseases Infections Inflammation Pathologic Processes Pathological Conditions, Signs and Symptoms Sepsis Systemic Inflammatory Response Syndrome

Age range

16 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Seoul National University Hospital

Seoul, 110-744, South Korea

Location status: Recruiting

Location contact

Gil Joon Suh, MD, PhD

PRINCIPAL_INVESTIGATOR

Kyung Su Kim, MD, PhD

CONTACT

Kyung Su Kim, MD, PhD

SUB_INVESTIGATOR

Woon Yong Kwon, MD, PhD

SUB_INVESTIGATOR

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age over 16 years old
  • Admitted to ICU
  • Diagnosed as having sepsis or as postresuscitation status
  • Definition of sepsis: 2 or more SIRS criteria + infection is suspected
  • Definition of postresuscitation status: Survived from non-traumatic cardiac arrest

Exclusion criteria

  • refusal to participate
  • DNAR status

Treatment and study plan

Primary outcomes

  1. 1-month mortality

    Time frame: 1 month

    All cause mortality within 1-month

Secondary outcomes

  1. Hospital mortality

    Time frame: until hospital discharge, an expected average of 2 weeks

    All cause mortality during hospitalization

  2. ICU length of stay

    Time frame: Until ward transfer or discharge, an expected average of 7 days

  3. Favorable neurologic outcome

    Time frame: at discharge, an expected average of 2 weeks and at 6-month

    Favorable neurologic outcome is used for outcome measure in postresuscitation patients only.

    Favorable neurologic outcome means cerebral performance category 1 and 2. This outcome is measured at discharge and 6-month after admission.

Study contacts

Contact information is provided by the study sponsor or research team.

Kyung Su Kim, MD, PhD

CONTACT

[email protected]

82-10-8033-1127

Sponsors and collaborators

Lead sponsor

Seoul National University Hospital

Other

Registry information

Official study title

Repository for Samples Collected From Sepsis and Postresuscitation Patients in Emergency Intensive Care Unit

Important dates

Study start
2006
Primary completion
2028
Study completion
2028
First posted
Aug 22, 2012
Registry last updated
Nov 24, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.